Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.27% |
| 2 | Technology | 12.59% |
| 3 | Healthcare | 10.49% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Cenovus Energy
CVE
$52.1B
| $9.6M | 0.01% |
957,718
-498,276
| -34% | -$4.08M |
|
1277
Columbia Banking Systems
COLB
$8.78B
| $9.59M | 0.01% |
227,808
+25,029
| +12% | +$968K |
|
|
CBIO
1278
Crescent Biopharma
CBIO
$610M
| $9.58M | 0.01% |
6,850
-6,919
| -50% | -$8.12M |
|
|
TUP
1279
DELISTED
Tupperware Brands Corporation
TUP
| $9.56M | 0.01% |
154,721
-75,190
| -33% | -$4.64M |
|
1280
OR Royalties Inc
OR
$6.02B
| $9.56M | 0.01% |
740,708
-768,398
| -51% | -$9.94M |
|
1281
SiriusXM
SIRI
$10.1B
| $9.54M | 0.01% |
172,917
+168,743
| +4,043% | +$9.34M |
|
1282
Energy Recovery
ERII
$446M
| $9.54M | 0.01% |
1,207,986
-553,475
| -31% | -$3.95M |
|
1283
Virtus Investment Partners
VRTS
$1.09B
| $9.52M | 0.01% |
+82,030
| New | +$9.16M |
|
|
INST
1284
DELISTED
Instructure, Inc.
INST
| $9.52M | 0.01% |
287,065
+190,480
| +197% | +$5.88M |
|
1285
Mitsubishi UFJ Financial
MUFG
$254B
| $9.5M | 0.01% |
1,475,709
+977,356
| +196% | +$6.17M |
|
1286
Gibraltar Industries
ROCK
$1.51B
| $9.5M | 0.01% |
305,102
+284,304
| +1,367% | +$8.58M |
|
1287
Phibro Animal Health
PAHC
$1.44B
| $9.47M | 0.01% |
255,574
+90,153
| +54% | +$3.39M |
|
|
SIVB
1288
DELISTED
SVB Financial Group
SIVB
| $9.46M | 0.01% |
50,573
-27,078
| -35% | -$4.76M |
|
1289
Par Pacific Holdings
PARR
$3.45B
| $9.44M | 0.01% |
454,032
+399,972
| +740% | +$7.25M |
|
1290
Toll Brothers
TOL
$14.1B
| $9.39M | 0.01% |
226,399
-3,162,733
| -93% | -$124M |
|
1291
Telefônica Brasil
VIV
$19.3B
| $9.38M | 0.01% |
592,392
-162,088
| -21% | -$2.46M |
|
1292
CALL
Zimmer Biomet
ZBH
$18.5B
| $9.37M | 0.01% |
82,400
+30,900
| +60% | +$3.57M |
|
1293
Fair Isaac
FICO
$22.3B
| $9.29M | 0.01% |
+66,118
| New | +$9.26M |
|
1294
VeriSign
VRSN
$26.4B
| $9.27M | 0.01% |
87,160
+49,794
| +133% | +$5.01M |
|
|
CBI
1295
DELISTED
Chicago Bridge & Iron Nv
CBI
| $9.27M | 0.01% |
551,897
-1,449,149
| -72% | -$22.2M |
|
|
TAHO
1296
DELISTED
Tahoe Resources Inc
TAHO
| $9.26M | 0.01% |
1,756,788
+1,589,706
| +951% | +$8.65M |
|
1297
MillerKnoll
MLKN
$1.61B
| $9.25M | 0.01% |
257,775
+183,483
| +247% | +$6.17M |
|
1298
Gildan
GIL
$10.8B
| $9.25M | 0.01% |
+295,574
| New | +$9.05M |
|
1299
M&T Bank
MTB
$36.1B
| $9.24M | 0.01% |
57,351
-300,295
| -84% | -$47.2M |
|
|
RARX
1300
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $9.22M | 0.01% |
631,757
+434,042
| +220% | +$6.56M |
|
Similar funds
Millennium Management's Q3 2017 Portfolio in Review
As of Q3 2017, Millennium Management held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Millennium Management deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Millennium Management's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Millennium Management added most to Salesforce in Q3 2017, an estimated $208M increase.
- Millennium Management's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Millennium Management fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Millennium Management's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Millennium Management opened 794 new positions and closed 737 in Q3 2017.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.